173 related articles for article (PubMed ID: 37716342)
1. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342
[TBL] [Abstract][Full Text] [Related]
2. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
4. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
Koller D; Vaitsekhovich V; Mba C; Steegmann JL; Zubiaur P; Abad-Santos F; Wojnicz A
Talanta; 2020 Feb; 208():120450. PubMed ID: 31816725
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
6. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma.
Guo ZX; Wu YE; Shi HY; van den Anker J; Liang P; Zheng Y; Zhao XW; Feng R; Zhao W
J Pharm Biomed Anal; 2023 Feb; 224():115159. PubMed ID: 36442459
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
8. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
Decosterd LA; Mercier T; Ternon B; Cruchon S; Guignard N; Lahrichi S; Pesse B; Rochat B; Burger R; Lamoth F; Pagani JL; Eggimann P; Csajka C; Choong E; Buclin T; Widmer N; André P; Marchetti O
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122160. PubMed ID: 32891946
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an analytical method using liquid chromatography-tandem mass spectrometry for the therapeutic drug monitoring of seven cardiovascular drugs in clinical usage.
Abady MM; Jeong JS; Kwon HJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123552. PubMed ID: 36469961
[TBL] [Abstract][Full Text] [Related]
10. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
[TBL] [Abstract][Full Text] [Related]
11. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
Llopis B; Robidou P; Tissot N; Pinna B; Gougis P; Aubart FC; Campedel L; Abbar B; Weil DR; Uzunov M; Gligorov J; Salem JE; Funck-Brentano C; Zahr N
J Pharm Biomed Anal; 2021 Apr; 197():113968. PubMed ID: 33618135
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.
Feng X; Ding Y; Zhang P; Fu Q; Zhang L; Zheng H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122940. PubMed ID: 34564058
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
Tachet J; Versace F; Mercier T; Buclin T; Decosterd LA; Choong E; Girardin FR
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov; 1230():123917. PubMed ID: 37956468
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
Aghai-Trommeschlaeger F; Zimmermann S; Gesierich A; Kalogirou C; Goebeler ME; Jung P; Pelzer T; Kurlbaum M; Klinker H; Isberner N; Scherf-Clavel O
Clin Biochem; 2022; 105-106():35-43. PubMed ID: 35483452
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
Wojnicz A; Colom-Fernández B; Steegmann JL; Muñoz-Calleja C; Abad-Santos F; Ruiz-Nuño A
Ther Drug Monit; 2017 Jun; 39(3):252-262. PubMed ID: 28490048
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of 10 antibiotics in plasma: Sulfosalicylic acid combined with 2D-LC-MS/MS is a robust assay for beta-lactam therapeutic drug monitoring.
Palayer M; Chaussenery-Lorentz O; Boubekeur L; Urbina T; Maury E; Maubert MA; Pilon A; Bourgogne E
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr; 1221():123685. PubMed ID: 37023569
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma.
Lou Y; Qin H; Hu Q; Chai Y; Zhou H; Chen M; Wang Q; Huang P; Gu J; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123394. PubMed ID: 35932695
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
[TBL] [Abstract][Full Text] [Related]
19. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
